Singular Health Group Ltd has released a press release.
Preliminary Final Report
Filed with ASX ·
6ix hasn’t read this filing yet.
Singular Health Group Ltd on 6ix
Earlier from Singular Health
- Strategic Investment from Master Distributor in USA
- Appointment of Master Distributor in the United States
- Capital Raise & Corporate Mandate
- Resignation of Managing Director and Strategic Review
- Operational Update, R&D Funding Facility & Strategic Review
Later from Singular Health
- Appointment of Managing Director and Chief Executive Officer
- Singular Receives R&D Tax Incentive Refund
- Singular Receives Commitment for $850,000 from CG1 Ventures
- Enterprise Licence Order Received for 3Dicom R&D Software
- First 3Dicom Enterprise Sale Received in United States
Follow Singular Health into a list and get an email when it puts out news.
Follow Singular Health